Profile
International Journal of Diabetes & Clinical Diagnosis Volume 2 (2015), Article ID 2:IJDCD-113, 6 pages
http://dx.doi.org/10.15344/2394-1499/2015/113
Research Article
Measuring Second Phase of Insulin Secretion by Components of Metabolic Syndrome

Yi-Tien Lin1, Chung-Ze Wu2, Wei-Cheng Lian3, Chun-Hsien Hsu4, Chang-Hsun Hsieh5, Dee Pei6, Yen-Lin Chen7 and Jiunn-Diann Lin2*

1Graduate Institute of Business Administration, Fu Jen Catholic University, Taipei, Taiwan
2Division of Endocrinology, Department of Internal Medicine, Shuang-Ho Hospital, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
3Division of Endocrinology and Metabolism, Department of Internal of Medicine, Buddhist Dalin Tzu Chi General Hospital and School of Medicine, Tzu Chi University, Taiwan
4Department of Family Medicine, Cardinal Tien Hospital, School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan
5Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical School
6Department of Internal Medicine, Cardinal Tien Hospital, Medical School, Catholic Fu Jen University, New Taipei City, Taiwan
7Department of Pathology, Cardinal Tien Hospital, School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan
Dr. Jiunn-Diann Lin, Department of Internal Medicine, Shuang Ho Hospital, No.291, Zhongzheng Rd., Zhonghe District, New Taipei City, 23561, Taiwan, Tel: +886-2-22490088; E-mail: jdlin1971@yahoo.com.tw
28 November 2015; 29 December 2015; 31 December 2015
Lin YT, Wu CZ, Lian WC, Hsu CH, Hsieh CH, et al. (2015) Measuring Second Phase of Insulin Secretion by Components of Metabolic Syndrome. Int J Diabetes Clin Diagn 2: 113. doi: http://dx.doi.org/10.15344/2394-1499/2015/113

References

  1. DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318-368. View
  2. Kahn SE (2003) The relative contributions of insulin resistance and betacell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46: 3-19. View
  3. Pratley RE, Weyer C (2001) The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia 44: 929-945. View
  4. Festa A, Williams K, D'Agostino R Jr, Wagenknecht LE, Haffner SM (2006) The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 55: 1114-1120. View
  5. Caumo A, Luzi L (2004) First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab 287: E371-385. View
  6. van Haeften TW1, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, et al. (2000) Relative conributions of beta-cell function and tissue insulin sensitivity to fasting and postglucose-load glycemia. Metabolism 49: 1318- 1325. View
  7. Yang CC, Lin JD, Kuo KL, Wu CZ, Li JC, et al. (2007)The comparison of second phase insulin secretion in patients treated with repaglinide or gliclazide. Diabetes & Metabolic Syndrome: Clinical Research & Reviews1: 37-42. View
  8. Lin JD, Hsia TL, Wu CZ, Su CC, Ma WY, et al. (2010) The first and second phase of insulin secretion in naive Chinese type 2 diabetes mellitus. Metabolism 59: 780-786. View
  9. Barg S, Eliasson L, Renström E, Rorsman P (2002) A subset of 50 secretory granules in close contact with L-type Ca2+ channels accounts for firstphase insulin secretion in mouse beta-cells. Diabetes 51 Suppl 1: S74-82. View
  10. van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, et al. (2002) Disturbances in beta-cell function in impaired fasting glycemia. Diabetes 51 Suppl 1: S265-270. View
  11. van Haeften TW, Dubbeldam S, Zonderland ML, Erkelens DW (1998) Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests. Diabetes Care 21: 278-282. View
  12. Weiss R, Caprio S, Trombetta M, Taksali SE, Tamborlane WV, et al. (2005) Beta-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 54: 1735-1743. View
  13. Vega GL (2001) Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity, the metabolic syndrome, and cardiovascular disease. Am Heart J 142: 1108-1116. View
  14. Bardini G, Dicembrini I, Pala L, Cresci B, Rotella CM (2011) Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance. Diabet Med 28: 1229-1233. View
  15. Hanley AJ, Wagenknecht LE, D'Agostino RB Jr, Zinman B, Haffner SM (2003) Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes 52: 2740-2747. View
  16. Mari A, Tura A, Pacini G, Kautzky-Willer A, Ferrannini E (2008) Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes. Diabet Med 25: 671-677. View
  17. American Diabetes Association (2009) The American Diabetes Association (ADA) has been actively involved in the development and dissemination of diabetes care standards, guidelines, and related documents for many years. Introduction. Diabetes Care 32 Suppl 1: S1-2. View
  18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. View
  19. Chiu KC, Chuang LM, Yoon C (2001) Comparison of measured and estimated indices of insulin sensitivity and beta cell function: impact of ethnicity on insulin sensitivity and beta cell function in glucose-tolerant and normotensive subjects. J Clin Endocrinol Metab 86: 1620-1625. View
  20. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-223. View
  21. Byrne MM, Sturis J, Polonsky KS (1995) Insulin secretion and clearance during low-dose graded glucose infusion. Am J Physiol 268: E21-27. View
  22. Godsland IF, Jeffs JA, Johnston DG (2004) Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47: 1157- 1166. View
  23. Park JY, Lee KU, Kim CH, Kim HK, Hong SK, et al. (1997) Past and current obesity in Koreans with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 35: 49-56. View
  24. Pei D, Hsiao CF, Hung YJ, Hsieh CH, Fang SC, et al. (2006) The insulin sensitivity, glucose sensitivity, and acute insulin response to glucose load in adolescent type 2 diabetes in Taiwanese. Diabetes Metab Res Rev 22: 26-33. View
  25. Klöppel G, Löhr M, Habich K, Oberholzer M, Heitz PU (1985) Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 4: 110-125. View
  26. Alford FP, Henriksen JE, Rantzau C, Vaag A, Hew LF, et al. (1998) Impact of family history of diabetes on the assessment of beta-cell function. Metabolism 47: 522-528. View
  27. Gower BA, Ard JD, Hunter GR, Fernandez J, Ovalle F (2007) Elements of the metabolic syndrome: association with insulin sensitivity and effects of ethnicity. Metab Syndr Relat Disord 5: 77-86. View
  28. Cavaghan MK, Ehrmann DA, Polonsky KS (2000) Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 106: 329-333. View
  29. Ko GT, Chan JC, Cockram CS, Woo J (1999) Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 23: 1136- 1142. View
  30. Bonadonna RC, Stumvoll M, Fritsche A, Muggeo M, Häring H, et al. (2003) Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. Diabetes 52: 470-480. View